Progenity to Report Fourth Quarter and Full-Year 2021 : vima

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for...

Related Keywords

Kristin Schaeffer , Chuck Padala , Progenity Inc , Nasdaq , Investor Relations , Nasdaq Prog , Progenity , Nc ,